Overview
This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.
Eligibility
Inclusion Criteria:patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery
Exclusion Criteria: age <16,severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.